Primary Site >> Pancreatic Cancer

Gene >> PRSS3

Journal: Gut. 2010 Nov;59(11):1535-44.
Title: PRSS3 promotes tumour growth and metastasis of human pancreatic cancer.
Author: Jiang, Guozhong|Cao, Fengyu|Ren, Guoping|Gao, Dongling|Bhakta, Vipul|Zhang, Yunhan|Cao, Hua|Dong, Ziming|Zang, Weidong|Zhang, Shuijun|Wong, Han Hsi|Hiley, Crispin|Crnogorac-Jurcevic, Tatjana|Lemoine, Nick R|Wang, Yaohe
PMID: 20947888
Journal: Biochem J. 2011 Nov 15;440(1):95-105.
Title: The P(2)' residue is a key determinant of mesotrypsin specificity: engineering a high-affinity inhibitor with anticancer activity.
Author: Salameh, Moh'd A|Soares, Alexei S|Hockla, Alexandra|Radisky, Derek C|Radisky, Evette S
PMID: 21806544
Journal: Mol Cancer Res. 2012 Dec;10(12):1555-66.
Title: PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer.
Author: Hockla, Alexandra|Miller, Erin|Salameh, Moh'd A|Copland, John A|Radisky, Derek C|Radisky, Evette S
PMID: 23258495
Journal: Gynecol Oncol. 2015 Jun;137(3):546-52.
Title: PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer.
Author: Ma, Ruiqiong|Ye, Xue|Cheng, Hongyan|Ma, Yu|Cui, Heng|Chang, Xiaohong
PMID: 25735255